Cochlear (ASX:COH) share price sinks: How did its result compare to expectations?

Here's what the market was expecting from Cochlear…

| More on:
An ASX investor looks devastated as he watches his computer screen, indicating bad news

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price has been the worst performer on the S&P/ASX 200 Index (ASX: XJO) on Friday.

In late afternoon trade, the hearing solutions company's shares are down 7% to $237.81.

Why is the Cochlear share price under pressure?

Investors have been selling down the Cochlear share price on Friday following the release of its full year results.

Although the company delivered a profit result in line with its guidance, it fell short of the market's expectations.

Unfortunately for the Cochlear share price, this was the case for its guidance for FY 2022 as well. This has left analysts scrambling to adjust their estimates and recommendations today.

How did Cochlear's result compare to expectations?

Goldman Sachs has been running the rule over the Cochlear result. It notes that the company's revenue was in line with expectations, but its earnings fell short.

The broker commented: "FY21 revenue in-line, earnings (2)% below. Revenue of $1,489m was in-line with consensus, with YoY growth of +19% representing a +1% CAGR from FY19. Gross margins fell 200bps from 75% to 73% (half driven by FX), whilst opex grew +5%, contributing to a (2)% earnings miss, albeit still comfortably within the middle of guided range ($237m vs. $225-245m)."

While that was disappointing, the biggest impact on the Cochlear share price appears to have been its guidance.

Goldman explained: "COH targets earnings of $265-285m in FY22, representing growth of +12-20% on a heavily Covid-impacted comparator, approximately (12)-(5)% below current consensus."

"Developed markets are expected to grow in FY22 but COH highlights that surgery rates remain highly variable and that, whilst guidance factors some continuing Covid impact, it does not consider a more material disruption that significantly impacts sales."

Goldman added: "It is worth highlighting that FY22 earnings guidance implies a +0-2% 3-year CAGR from FY19, suggesting the recovery will likely still take longer than for many other stocks in the sector."

Are its shares in the buy zone?

While Goldman Sachs hasn't updated its recommendation yet, it previously had a sell rating and $189.00 price target.

Given the above, it seems highly unlikely that the broker's opinion will change on the Cochlear share price once it has fully digested the result.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why CBA, Inghams, Praemium, and Strike Energy shares are tumbling today

These shares are having a tough time on Tuesday. But why?

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Brightstar, Eagers Automotive, Regis Resources, and Westpac shares are sinking

These shares are starting the week in the red. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 29Metals, CAR Group, DroneShield, and Santana Minerals shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Imricor, Imugene, Newmont, and Pepper Money shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Cromwell Property, Metcash, Pilbara Minerals, and Tyro shares are falling today

Let's see why these shares are under pressure on Tuesday.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Block, Computershare, South32, and Strickland Metals shares are falling today

These shares are starting the week in the red. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today

These shares are ending the week in the red. But why?

Read more »